ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma

Fabio Bagante¹, Timothy M Pawlik^{2

3}

Affiliations

¹ Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
² Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. tim.pawlik@osumc.edu.
³ Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University, Wexner Medical Center, Columbus, OH, USA. tim.pawlik@osumc.edu.

Comment

Fabio Bagante et al. Ann Surg Oncol. 2018 Dec.

. 2018 Dec;25(Suppl 3):784-785.

doi: 10.1245/s10434-018-6856-0. Epub 2018 Oct 4.

Fabio Bagante¹, Timothy M Pawlik^{2

3}

¹ Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
² Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. tim.pawlik@osumc.edu.
³ Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University, Wexner Medical Center, Columbus, OH, USA. tim.pawlik@osumc.edu.

No abstract available

Comment on

The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
Zhang XF, Squires MH 3rd, Bagante F, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Weiss M, Scoggins C, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR, Pawlik TM. Zhang XF, et al. Ann Surg Oncol. 2018 May;25(5):1140-1149. doi: 10.1245/s10434-018-6382-0. Epub 2018 Feb 22. Ann Surg Oncol. 2018. PMID: 29470820